Factors associated with overall survival (OS) in 103 Triple-negative canine invasive mammary carcinomas. Univariate (log rank test) and multivariate survival analyses (Cox proportional hazard regression). HR: Hazard Ratio, 95 % CI: 95 % Confidence Interval, IGF1R: Insulin-like Growth Factor type 1 Receptor, LVI: Lymphovascular Invasion. When several significant prognostic factors overlapped, only one was selected for the multivariate analysis (LVI was chosen between lymph node status and LVI because it could have been determined in all cases). (DOC 38 kb
Immunohistochemistry and manual scoring analysis of Australian Breast Cancer Tissue Bank patient sam...
Factors associated with disease free interval of COS33 patients in a univariate analysis. (DOCX 15Â ...
Figure S5. Wnt2 and Frizzled9 expression are inversely correlated with IGF-1R expression in breast c...
Factors associated with specific survival (SS) in 103 Triple-negative canine invasive mammary carcin...
Factors associated with specific survival (SS) in 47 Luminal canine invasive mammary carcinomas. Uni...
Significant associations between IGF1R expression and clinicopathological features of 47 luminal can...
Primary antibodies and immunohistochemical protocols (Benchmark XT Ventana, Roche Diagnostics). All ...
(1.1) Hormone levels, reproductive states, cycle stages, and relative gene expression of receptors i...
Breast cancer cell viability dose curves in response to SKI-II. Refer to Fig. 5 for experimental det...
Histology analysis of extra MFP tumor developed in later stage in a mouse treated with MEDI3039. (A)...
Table S3. Updated and expanded annotation of canine osteosarcoma GWAS loci. Table S4. Gene list for ...
Immunohistochemical analysis of nuclear IGFBP-3 in HCC1806 tumors from control, gefitinib-treated (G...
Prognostic survival outcomes in relation to IGF1R protein expression in HER2 and PR-positive and neg...
Validation of ALDH as a CSC Marker in Dog PDX Tumors. A. A dog sarcoma PDX tumor was allowed to grow...
Figure S2. Estrogen receptor expression in non-malignant and tumoral canine and feline mammary cell ...
Immunohistochemistry and manual scoring analysis of Australian Breast Cancer Tissue Bank patient sam...
Factors associated with disease free interval of COS33 patients in a univariate analysis. (DOCX 15Â ...
Figure S5. Wnt2 and Frizzled9 expression are inversely correlated with IGF-1R expression in breast c...
Factors associated with specific survival (SS) in 103 Triple-negative canine invasive mammary carcin...
Factors associated with specific survival (SS) in 47 Luminal canine invasive mammary carcinomas. Uni...
Significant associations between IGF1R expression and clinicopathological features of 47 luminal can...
Primary antibodies and immunohistochemical protocols (Benchmark XT Ventana, Roche Diagnostics). All ...
(1.1) Hormone levels, reproductive states, cycle stages, and relative gene expression of receptors i...
Breast cancer cell viability dose curves in response to SKI-II. Refer to Fig. 5 for experimental det...
Histology analysis of extra MFP tumor developed in later stage in a mouse treated with MEDI3039. (A)...
Table S3. Updated and expanded annotation of canine osteosarcoma GWAS loci. Table S4. Gene list for ...
Immunohistochemical analysis of nuclear IGFBP-3 in HCC1806 tumors from control, gefitinib-treated (G...
Prognostic survival outcomes in relation to IGF1R protein expression in HER2 and PR-positive and neg...
Validation of ALDH as a CSC Marker in Dog PDX Tumors. A. A dog sarcoma PDX tumor was allowed to grow...
Figure S2. Estrogen receptor expression in non-malignant and tumoral canine and feline mammary cell ...
Immunohistochemistry and manual scoring analysis of Australian Breast Cancer Tissue Bank patient sam...
Factors associated with disease free interval of COS33 patients in a univariate analysis. (DOCX 15Â ...
Figure S5. Wnt2 and Frizzled9 expression are inversely correlated with IGF-1R expression in breast c...